FDA Drug recall D-1743-2019
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd
- FDA Drug
- Class III
- terminated
- Published 2019-08-21
On 2019-08-21 the FDA classified a Class III recall of Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd by Glenmark Pharmaceuticals Usa, citing temperature Abuse: Complaints received of liquidy texture.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1743-2019 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-08-07 |
| Published | 2019-08-21 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Glenmark Pharmaceuticals Usa |
| Distribution | US |
Product
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Village: Kishanpura, Baddi Nalagarth Road, District: Solan, Himachal Pradesh-173205, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-298-17
Reason
Temperature Abuse: Complaints received of liquidy texture.
Identifiers
| ndc | 68462-298-17 |
|---|---|
| ndc | 68462-298-55 |
| code_info | Lot #: 05180734, Exp. 03/2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1743-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.